Genetic studies in familial hyperlipoproteinemia, and therapeutic implications
De Gennes, J.L.
Annales de Biologie Clinique 46(1): 1-3
1988
ISSN/ISBN: 0003-3898 PMID: 3389574 Document Number: 318949
Document emailed within 1 workday
Related Documents
Brown, M.S.; Goldstein, J.L. 1992: The genetic basis of hypercholesterolemia: clinical and therapeutic implications Zhonghua Yi Xue Za Zhi 49(2): 135-137Astakhova, L.N. 1980: Familial genetic studies in neuroarthritic diathesis in children Pediatriia 2: 47-50
Kolodny, E.H.; Boustany, R.M.; Rouleau, G.A.; Growden, J.H.; Martin, J.B. 1989: Familial spastic paraplegia: clinical observations and genetic studies Progress in Clinical and Biological Research 306: 205-211
Collignon, J.; Struman, I.; Tabruyn, S.; Josse, C.; Boukerroucha, M.; Jerusalem, G.; Bours, V. 2011: Molecular and genetic aspects of triple negative breast cancer and therapeutic implications Revue Medicale de Liege 66(5-6): 393-396
Matsuura, F. 2007: Familial hyperlipoproteinemia, type IV Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 326-328
Sakoda, S.; Suzuki, T.; Higa, S.; Ueji, M.; Kishimoto, S.; Hayashi, A.; Yasuda, N.; Takaba, Y.; Nakajima, A. 1983: Genetic studies of familial amyloid polyneuropathy in the Arao district of Japan: I. The genealogical survey Clinical Genetics 24(5): 334-338
Gorwood, P.; Feingold, J.; Ades, J. 1999: Genetic epidemiology and psychiatry (I): scope and limitations of familial studies. Case of panic disorder L'Encephale 25(1): 21-29
Di Gruttola, G.; Ferrara, M. 1977: Familial congenital type IIB hyperlipoproteinemia La Pediatria 85(3): 435-442
O'Malley, M.P.; Haake, A.; Goldsmith, L.; Berg, D. 1997: Localized Darier disease. Implications for genetic studies Archives of Dermatology 133(9): 1134-1138
Andersen, G.E.; Friis-Hansen, B. 1976: Neonatal diagnosis of familial type Ii hyperlipoproteinemia Pediatrics 57(2): 214-220
Traurig, J.; Sobra, J.; Kvasilová, M.; Wildtová, Z. 1978: Familial hyperlipoproteinemia type IIA with homozygotic manifestations in a heterozygote Vnitrni Lekarstvi 24(7): 684-690
Aronoff, G.R. 1992: Therapeutic implications associated with renal studies of nabumetone Journal of Rheumatology. Suppl 36: 25-31
Zúñiga, J.; Vargas-Alarcón, G.; Salgado, N.; Flores, C.; Martínez-Tripp, S.; Miranda, A.; Balbuena, A.; Osnaya, N.; Juárez, F.; Granados, J.; Reyes-Terán, G. 2000: Genetic determinant factors of resistance to HIV infection and of control of progression to AIDS: implications on pathogenesis and therapeutic approaches for the eradication of HIV. a review Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 52(3): 284-295
Arranz Peña, M.L.; Alonso de la Peña, M.C. 1985: Hyperlipoproteinemia type I. Study of a familial deficiency of lipoprotein-lipase Revista Clinica Espanola 176(2): 98-100
Kuŝić, M.; Gavrilović, M.; Mihajloviĉ, M.; Boŝković, B. 1980: Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol Srpski Arhiv Za Celokupno Lekarstvo 108(9): 875-881
Syc, S.; Kujawski, J. 1973: Case of acute renal failure during pancreatitis in a patient with familial hyperlipoproteinemia Wiadomosci Lekarskie 26(3): 243-245
Cortellazzo, S.; Orlando, R.; Ortolani, C.; Brun, G.D.; Okolicsànyi, L. 1976: Therapeutic afficacy of UDPG in non-hemolytic familial jaundice: metabolic studies in a patient with Dubin-Johnson syndrome. Ii La Clinica Terapeutica 77(5): 459-472
Remacha, A.F.; del Río, E.; Baiget, M. 1998: Atypical familial microcytosis: a familial and genetic study Medicina Clinica 110(5): 183-185
Koffigan, M.; Fruchart, J.C.; Dhondt, J.L.; Moschetto, Y.; Farriaux, J.P. 1982: Apolipoprotein B measurement in blood spotted on paper (a screening test for familial type II A hyperlipoproteinemia) La Ricerca in Clinica E in Laboratorio 12(1): 169-172
Gar'kavtseva, R.F.; Sitnikova, T.S.; Kazubskaia, T.P.; Demidov, L.V.; Kharkevich, G.I. 1995: Clinico-genetic aspects of cutaneous melanoma. I. Incidence, familial study, genetic heterogeneity Genetika 31(11): 1557-1561